Movement Alert｜Elevance Health Rises 5.25% in Pre-Market Trading, Multiple Investment Banks Raise Price Targets Ahead of Q2 Earnings

Market Focus

07/14

On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions just ahead of the company's Q2 earnings release scheduled for July 15.

On the news front, Wells Fargo significantly raised its price target from $391 to $492 while maintaining an Overweight rating; Truist lifted its target to $475, keeping a Buy rating; and Bernstein raised its target to $482, maintaining an Outperform rating. The FactSet consensus target price has climbed to approximately $439. Market consensus expects Q2 revenue of $48.714 billion, representing 0.99% year-over-year growth, with adjusted EPS of $6.20.

The broader healthcare insurance sector is approaching a critical test as Elevance, UnitedHealth, and CVS Health report Q2 results sequentially. Goldman Sachs noted that underwriting conditions for managed care companies are improving. Elevance delivered a strong Q1 beat with adjusted EPS of $12.58 versus the $10.79 estimate, and management reaffirmed full-year adjusted EPS guidance of at least $26.75.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1105657461"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105657461\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105657461?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-14 21:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105657461","market":"us","top_or_hot":-1,"title":"Movement Alert｜Elevance Health Rises 5.25% in Pre-Market Trading, Multiple Investment Banks Raise Price Targets Ahead of Q2 Earnings","media":"Market Focus","content":"<p><p>On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions just ahead of the company's Q2 earnings release scheduled for July 15.</p><p>On the news front, Wells Fargo significantly raised its price target from $391 to $492 while maintaining an Overweight rating; Truist lifted its target to $475, keeping a Buy rating; and Bernstein raised its target to $482, maintaining an Outperform rating. The FactSet consensus target price has climbed to approximately $439. Market consensus expects Q2 revenue of $48.714 billion, representing 0.99% year-over-year growth, with adjusted EPS of $6.20.</p><p>The broader healthcare insurance sector is approaching a critical test as Elevance, UnitedHealth, and CVS Health report Q2 results sequentially. Goldman Sachs noted that underwriting conditions for managed care companies are improving. Elevance delivered a strong Q1 beat with adjusted EPS of $12.58 versus the $10.79 estimate, and management reaffirmed full-year adjusted EPS guidance of at least $26.75.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Elevance Health Rises 5.25% in Pre-Market Trading, Multiple Investment Banks Raise Price Targets Ahead of Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Elevance Health Rises 5.25% in Pre-Market Trading, Multiple Investment Banks Raise Price Targets Ahead of Q2 Earnings\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time smaller\">2026-07-14 21:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><p>On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions just ahead of the company's Q2 earnings release scheduled for July 15.</p><p>On the news front, Wells Fargo significantly raised its price target from $391 to $492 while maintaining an Overweight rating; Truist lifted its target to $475, keeping a Buy rating; and Bernstein raised its target to $482, maintaining an Outperform rating. The FactSet consensus target price has climbed to approximately $439. Market consensus expects Q2 revenue of $48.714 billion, representing 0.99% year-over-year growth, with adjusted EPS of $6.20.</p><p>The broader healthcare insurance sector is approaching a critical test as Elevance, UnitedHealth, and CVS Health report Q2 results sequentially. Goldman Sachs noted that underwriting conditions for managed care companies are improving. Elevance delivered a strong Q1 beat with adjusted EPS of $12.58 versus the $10.79 estimate, and management reaffirmed full-year adjusted EPS guidance of at least $26.75.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELV","symbol_name":"Elevance Health","start_time":0,"source_url":"","article_id":"1105657461","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105657461","pubTimestamp":1784035572,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ELV":"Elevance Health"},"translate_title":"走势警报|Elevance Health 在盘前交易中上涨 5.25%，多家投资银行在第二季度收益公布前上调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions just ahead of the company's Q2 earnings release scheduled for July 15.On the news front, Wells Fargo significantly raised its price target from $391 to $492 while maintaining an Overweight rating; Truist lifted its target to $475, keeping a Buy rating; and Bernstein raised its target to $482, maintaining an Outperform rating. The FactSet consensus target price has climbed to approximately $439. Market consensus expects Q2 revenue of $48.714 billion, representing 0.99% year-over-year growth, with adjusted EPS of $6.20.The broader healthcare insurance sector is approaching a critical test as Elevance, UnitedHealth, and CVS Health report Q2 results sequentially. Goldman Sachs noted that underwriting conditions for managed care companies are improving. Elevance delivered a strong Q1 beat with adjusted EPS of $12.58 versus the $10.79 estimate, and management reaffirmed full-year adjusted EPS guidance of at least $26.75.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}